Clinical trial
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
NCT01982435
Study timeline
Study start (actual)2014-06-24Date precision: day
Registry last updated2020-11-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Macular Edemaunresolved
Interventions
RanibizumabDRUG · verified · RxNorm: ranibizumab
RanibizumabDRUG · verified · RxNorm: ranibizumab
Sponsors & collaborators
Justis Ehlerslead sponsor
Genentech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01982435 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.